News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
The FNIH has named Vinod Balachandran, MD, recipient of the 2023 Trailblazer Prize for Clinician-Scientists – Foundation for the National Institutes of Health
Photo taken from: Foundation for the National Institutes of Health / Twitter
Aug 25, 2023, 21:22

The FNIH has named Vinod Balachandran, MD, recipient of the 2023 Trailblazer Prize for Clinician-Scientists – Foundation for the National Institutes of Health

The Foundation for the National Institutes of Health, made the following announcement on Twitter:

“The FNIH has named Vinod Balachandran, MD, recipient of the 2023 Trailblazer Prize for Clinician-Scientists for his groundbreaking research on new immunotherapies for pancreatic cancer.

Read the full press release here https://bit.ly/44nZtvV ”

Source: Foundation for the National Institutes of Health / Twitter

award cancer Foundation for the National Institutes of Health OncoDaily Oncology Vinod Balachandran
Special Coverage
Blog
Aug 31, 2024, 19:25
Lucas Family's Fight Against Childhood Cancer
Blog
Aug 31, 2024, 18:55
Miriam Mutebi: Caregivers play a vital role in the cancer care journey
Blog
Aug 31, 2024, 18:36
Asaf Maoz: Looking Back, Facing Forward is coming up September 14th
Insight
Aug 31, 2024, 18:34
Erman Akkus: First line treatment of metastatic Colorectal Cancer in older patients
Blog
Aug 31, 2024, 18:32
Matthias Ocker: Novel small molecule MCL-1 inhibitor in vivo clearance and robust efficacy in solid and hematological tumor models
Insight
Aug 31, 2024, 18:28
Sharon Baumel-Alterzon: I will be opening my own lab in Oct 2024 at City of Hope
Blog
Aug 31, 2024, 18:27
Julie McCrossin: Sze Yarn Sin’s presentation on proton therapy
Insight
Aug 31, 2024, 18:25
Maqbul Jamil: Do Australians live longer?
Blog
Aug 31, 2024, 18:21
Funding available for SIOP Member Project Ideas
Blog
Aug 31, 2024, 18:14
Raffaele Giusti: Time Toxicity of Cancer Treatment - Discussion at ESMO 2024
Drugs
Aug 31, 2024, 17:49
Mark Lewis: From the first day of fellowship I was taught to “respect oxaliplatin"
Insight
Aug 31, 2024, 17:42
Miriam Mutebi: Opportunity to coordinate Africa's biggest cancer congress and be a part of impactful change